NO975729L - Forbindelser og peptider som binder til etytropoietinreseptoren - Google Patents
Forbindelser og peptider som binder til etytropoietinreseptorenInfo
- Publication number
- NO975729L NO975729L NO975729A NO975729A NO975729L NO 975729 L NO975729 L NO 975729L NO 975729 A NO975729 A NO 975729A NO 975729 A NO975729 A NO 975729A NO 975729 L NO975729 L NO 975729L
- Authority
- NO
- Norway
- Prior art keywords
- hoc
- amino
- receptor
- ethytropoietin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,631 US5830851A (en) | 1993-11-19 | 1995-06-07 | Methods of administering peptides that bind to the erythropoietin receptor |
US08/484,635 US5773569A (en) | 1993-11-19 | 1995-06-07 | Compounds and peptides that bind to the erythropoietin receptor |
PCT/US1996/009810 WO1996040749A1 (en) | 1995-06-07 | 1996-06-07 | Compounds and peptides that bind to the erythropoietin receptor |
Publications (3)
Publication Number | Publication Date |
---|---|
NO975729D0 NO975729D0 (no) | 1997-12-05 |
NO975729L true NO975729L (no) | 1998-02-05 |
NO318783B1 NO318783B1 (no) | 2005-05-09 |
Family
ID=27048076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19975729A NO318783B1 (no) | 1995-06-07 | 1997-12-05 | Peptid som binder til erytropoietinreseptoren og anvendelse derav, samt farmasoytiske blandinger som inneholder peptidet. |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP1510524A3 (no) |
JP (3) | JP4050314B2 (no) |
KR (1) | KR100459984B1 (no) |
CN (1) | CN1192748A (no) |
AT (1) | ATE254138T1 (no) |
AU (1) | AU712713B2 (no) |
BR (1) | BR9609006A (no) |
CA (1) | CA2223833C (no) |
CZ (1) | CZ391097A3 (no) |
DE (1) | DE69630708T2 (no) |
ES (1) | ES2210374T3 (no) |
HU (1) | HUP9901069A2 (no) |
IL (1) | IL122417A0 (no) |
NO (1) | NO318783B1 (no) |
NZ (1) | NZ310804A (no) |
PL (1) | PL185040B1 (no) |
TR (1) | TR199701557T2 (no) |
WO (1) | WO1996040749A1 (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773569A (en) * | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5830851A (en) * | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
DE19904406A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolcarbonsäuren |
DE19904396A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolbenzylamin-Derivate |
US6703480B1 (en) | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
US7259146B2 (en) | 2000-05-26 | 2007-08-21 | Ortho-Mcneil Pharmaceutical, Inc. | Neuroprotective peptides |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
WO2004060406A2 (en) | 2002-12-31 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Polymeric reagents comprising a ketone or a related functional group |
JP2007530440A (ja) | 2003-05-12 | 2007-11-01 | アフィーマックス・インコーポレイテッド | 新規ポリ(エチレングリコール)修飾化合物およびその用途 |
NZ563042A (en) | 2003-05-12 | 2008-09-26 | Affymax Inc | Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds |
US7528104B2 (en) * | 2003-05-12 | 2009-05-05 | Affymax, Inc. | Peptides that bind to the erythropoietin receptor |
WO2004101606A2 (en) | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
WO2005000360A2 (en) | 2003-05-23 | 2005-01-06 | Nektar Therapeutics Al, Corporation | Peg derivatives having an amidocarbonate linkage |
WO2005028539A2 (en) | 2003-09-17 | 2005-03-31 | Nektar Therapeutics Al, Corporation | Multi-arm polymer prodrugs |
PT1694363E (pt) | 2003-12-16 | 2014-02-20 | Nektar Therapeutics | Composições monodispersas de naloxol peguilado |
DK1725580T3 (da) * | 2004-03-17 | 2009-03-23 | Aplagen Gmbh | Isosterisk transformation |
US9085659B2 (en) | 2004-05-03 | 2015-07-21 | Nektar Therapeutics | Polymer derivatives comprising an imide branching point |
WO2005108463A2 (en) | 2004-05-03 | 2005-11-17 | Nektar Therapeutics Al, Corporation | Branched polyethylen glycol derivates comprising an acetal or ketal branching point |
EP1812461A2 (en) * | 2004-11-10 | 2007-08-01 | AplaGen GmbH | Molecules which promote hematopoiesis |
US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
AU2005310189A1 (en) * | 2004-11-11 | 2006-06-08 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
CN101198321A (zh) * | 2005-04-26 | 2008-06-11 | 味之素株式会社 | 骨髓祖红细胞分化诱导剂 |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
JP2008546732A (ja) * | 2005-06-23 | 2008-12-25 | アプラゲン ゲーエムベーハー | 多価化合物 |
US8071554B2 (en) * | 2005-08-05 | 2011-12-06 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and uses thereof |
MX2008011389A (es) * | 2006-03-09 | 2009-01-26 | Aplagen Gmbh | Moleculas modificadas las cuales promueven hematopoyesis. |
CN101528263B (zh) | 2006-06-30 | 2013-01-23 | Sku资产管理有限公司 | 用于癌症的先天性免疫方法的缀合物 |
US8106154B2 (en) | 2007-01-31 | 2012-01-31 | Affymax, Inc. | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
EP2018835B1 (de) | 2007-07-09 | 2014-03-05 | Augustinus Bader | Wirkstoff abgebendes Pflaster |
CN101456911A (zh) * | 2007-12-12 | 2009-06-17 | 江苏豪森药业股份有限公司 | 促红细胞生成素模拟肽衍生物及其可药用盐和其制备方法与用途 |
WO2009142679A2 (en) * | 2008-03-26 | 2009-11-26 | Orthologic Corp. | Methods for treating acute myocardial infarction |
US8575102B2 (en) | 2008-08-01 | 2013-11-05 | Nektar Therapeutics | Conjugates having a releasable linkage |
MX2011001583A (es) | 2008-08-11 | 2011-04-04 | Nektar Therapeutics | Conjugados de alcanoato polimericos de multiples brazos. |
EP2331139B1 (en) | 2008-09-11 | 2019-04-17 | Nektar Therapeutics | Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method |
US20110166063A1 (en) | 2008-09-19 | 2011-07-07 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
KR101647164B1 (ko) * | 2008-09-26 | 2016-08-09 | 암브룩스, 인코포레이티드 | 변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도 |
WO2010148365A2 (en) * | 2009-06-19 | 2010-12-23 | The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona For And On Behalf Of Arizona State University | Compound arrays for sample profiling |
WO2011012306A2 (en) | 2009-07-30 | 2011-02-03 | Aplagen Gmbh | Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis |
ES2632164T3 (es) | 2010-07-06 | 2017-09-11 | Augustinus Bader | Aplicación tópica de eritropoyetina para uso en el tratamiento de lesiones de la córnea |
WO2012088445A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
WO2012088422A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
WO2012166555A1 (en) | 2011-05-27 | 2012-12-06 | Nektar Therapeutics | Water - soluble polymer - linked binding moiety and drug compounds |
JPWO2013171810A1 (ja) | 2012-05-14 | 2016-01-07 | パナソニックIpマネジメント株式会社 | 耐熱性抗体提示ファージを得る方法 |
CN103450348B (zh) * | 2012-05-29 | 2016-03-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种促红细胞生成素模拟肽、其制备方法和用途 |
CN106608906A (zh) * | 2015-10-22 | 2017-05-03 | 天津药物研究院有限公司 | 一种具有刺激红细胞生成功能的环形多肽的制备及其应用 |
CN106928338A (zh) * | 2015-12-31 | 2017-07-07 | 杭州阿德莱诺泰制药技术有限公司 | 促红细胞生成素肽及衍生物和聚合物、制备方法和应用 |
GB201609083D0 (en) | 2016-05-24 | 2016-07-06 | Syntab Therapeutics Gmbh | Synthetic compound |
CN113166203A (zh) * | 2018-09-14 | 2021-07-23 | Epo医药株式会社 | 抗促红细胞生成素受体肽 |
US20220296521A1 (en) | 2019-06-10 | 2022-09-22 | Respira Therapeutics, Inc. | Carrier-based formulations and related methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
WO1990008822A1 (en) * | 1989-02-03 | 1990-08-09 | Genetics Institute, Inc. | Erythropoietin receptor |
DE3924746A1 (de) * | 1989-07-26 | 1991-01-31 | Behringwerke Ag | Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
-
1996
- 1996-06-07 IL IL12241796A patent/IL122417A0/xx unknown
- 1996-06-07 KR KR1019970709231A patent/KR100459984B1/ko not_active IP Right Cessation
- 1996-06-07 EP EP03025811A patent/EP1510524A3/en not_active Withdrawn
- 1996-06-07 JP JP50202397A patent/JP4050314B2/ja not_active Expired - Fee Related
- 1996-06-07 WO PCT/US1996/009810 patent/WO1996040749A1/en active IP Right Grant
- 1996-06-07 PL PL96323858A patent/PL185040B1/pl not_active IP Right Cessation
- 1996-06-07 CZ CZ973910A patent/CZ391097A3/cs unknown
- 1996-06-07 DE DE69630708T patent/DE69630708T2/de not_active Expired - Lifetime
- 1996-06-07 NZ NZ310804A patent/NZ310804A/xx not_active IP Right Cessation
- 1996-06-07 CN CN96196094A patent/CN1192748A/zh active Pending
- 1996-06-07 CA CA2223833A patent/CA2223833C/en not_active Expired - Fee Related
- 1996-06-07 TR TR97/01557T patent/TR199701557T2/xx unknown
- 1996-06-07 AU AU61667/96A patent/AU712713B2/en not_active Ceased
- 1996-06-07 AT AT96919296T patent/ATE254138T1/de not_active IP Right Cessation
- 1996-06-07 BR BR9609006-5A patent/BR9609006A/pt unknown
- 1996-06-07 HU HU9901069A patent/HUP9901069A2/hu unknown
- 1996-06-07 EP EP96919296A patent/EP0886648B8/en not_active Expired - Lifetime
- 1996-06-07 ES ES96919296T patent/ES2210374T3/es not_active Expired - Lifetime
-
1997
- 1997-12-05 NO NO19975729A patent/NO318783B1/no not_active IP Right Cessation
-
2007
- 2007-07-18 JP JP2007186814A patent/JP2007277264A/ja active Pending
-
2009
- 2009-08-31 JP JP2009200615A patent/JP2009280616A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BR9609006A (pt) | 1999-12-14 |
NO318783B1 (no) | 2005-05-09 |
CN1192748A (zh) | 1998-09-09 |
EP0886648B8 (en) | 2004-03-03 |
ES2210374T3 (es) | 2004-07-01 |
JP2007277264A (ja) | 2007-10-25 |
EP0886648A4 (en) | 2000-01-12 |
DE69630708T2 (de) | 2004-08-05 |
ATE254138T1 (de) | 2003-11-15 |
KR19990022656A (ko) | 1999-03-25 |
PL323858A1 (en) | 1998-04-27 |
NZ310804A (en) | 1998-10-28 |
EP1510524A3 (en) | 2006-06-07 |
AU6166796A (en) | 1996-12-30 |
TR199701557T2 (xx) | 2002-06-21 |
HUP9901069A2 (hu) | 1999-07-28 |
EP1510524A2 (en) | 2005-03-02 |
EP0886648A1 (en) | 1998-12-30 |
DE69630708D1 (de) | 2003-12-18 |
JP2009280616A (ja) | 2009-12-03 |
AU712713B2 (en) | 1999-11-11 |
CZ391097A3 (cs) | 1998-07-15 |
JPH11507367A (ja) | 1999-06-29 |
KR100459984B1 (ko) | 2005-06-20 |
NO975729D0 (no) | 1997-12-05 |
EP0886648B1 (en) | 2003-11-12 |
CA2223833C (en) | 2010-12-21 |
PL185040B1 (pl) | 2003-02-28 |
CA2223833A1 (en) | 1996-12-19 |
WO1996040749A1 (en) | 1996-12-19 |
JP4050314B2 (ja) | 2008-02-20 |
IL122417A0 (en) | 1998-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975729L (no) | Forbindelser og peptider som binder til etytropoietinreseptoren | |
NO961115L (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
DK0765394T3 (da) | Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse | |
FI954805A (fi) | Menetelmiä insuliininkaltaisen kasvutekijän sitojaproteiinien käyttämiseksi | |
DE59409672D1 (de) | Festphasensynthese von Oligoribonucleotiden | |
NO910982L (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
NO950477D0 (no) | Aminosyrederivater | |
DE68925275D1 (de) | Endotoxin-bindeprotein und dessen verwendung | |
AU4375493A (en) | Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof | |
SE9602822D0 (sv) | New receptor | |
DE69929454D1 (de) | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
CA2199403A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
DE69315730D1 (de) | Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu | |
NO974713L (no) | Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider | |
CA2199843A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. | |
Lee et al. | Major Courses for the Biology Teacher Training Institutes | |
Yun et al. | Qualitative Changes, Amino Acid Compositions of Cuticular Proteins during Pupariation of Blowfly, Lucilia illustris | |
EP0716146A3 (en) | A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein | |
WO2004054907A3 (en) | Ftsz-polypeptides as a target for herbicidal compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |